CliffBio
biologic

Novarel

chorionic gonadotropin

Loss of exclusivityJanuary 1986projected — 12-year biologic exclusivity estimate
CompanyFerring Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNovarel
Active ingredientchorionic gonadotropin
Strength5,000UNITS
Dosage formFor Injection
RouteIntramuscular
ModalityBiologic
FDA approvalJanuary 1974
Marketing statusRx

More from Ferring Pharmaceuticals

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Novarel patent cliff — loss of exclusivity January 1986 | CliffBio